Endometrial cancer is one of the few cancers that doesn’t stay quiet. That’s why you should never brush off spotting between periods or any bleeding after menopause. When caught early, this ...

Pain during examination Difficulty locating the uterus Difficulty obtaining a clear image during an ultrasound The necessity of a rectovaginal exam Pregnancy complications: Very rarely, a retroverted ...

Uterine atony—also called atony of the uterus—occurs when the uterine muscles don't tighten after delivering a baby. If the muscles don't contract, the bleeding doesn't stop, causing postpartum ...

Schonfeld SJ, Hartge P, Pfeiffer, RM, et al. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer 2012 Dec 20. doi: 10.1002/cncr.27909. [Epub ahead of print] It ...

The combination of lenvatinib and pembrolizumab showed promising results in treating recurrent endometrial carcinoma, demonstrating significant antitumor activity and improved survival rates compared ...

Uterine fibroids are tumors made of muscle that can grow on your uterus. They rarely turn into cancer. Many women have uterine fibroids. You might not even know you have them, since they don’t ...

That leads to excessive cell growth. Many conditions can cause abnormal bleeding. To identify what type of bleeding is happening, Endometrial hyperplasia or not, you can do the following tests, as ...

Endometrial cancer is a type of tumour that arises in the tissue lining the uterus. Most endometrial cancers are adenocarcinomas; that is, cancers formed from cells that make and release mucus and ...

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales. Theramex's GnRH antagonist Yselty (linzagolix ...

Investigations would include checking haemoglobin levels, renal and liver function, coagulation disorders, ultrasound scans, cervical cytology and an endometrial biopsy. The doctor would want to ...

The FDA has cleared GSK's PD-1 inhibitor Jemperli as a treatment for all adult patients with primary advanced or recurrent endometrial cancer, a key part of the company's growth ambitions for the ...